232 related articles for article (PubMed ID: 20425006)
1. Inflammasome and IL-1beta-mediated disorders.
Hoffman HM; Wanderer AA
Curr Allergy Asthma Rep; 2010 Jul; 10(4):229-35. PubMed ID: 20425006
[TBL] [Abstract][Full Text] [Related]
2. The NLRP3 inflammasome in health and disease: the good, the bad and the ugly.
Menu P; Vince JE
Clin Exp Immunol; 2011 Oct; 166(1):1-15. PubMed ID: 21762124
[TBL] [Abstract][Full Text] [Related]
3. Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome.
Mitroulis I; Skendros P; Ritis K
Eur J Intern Med; 2010 Jun; 21(3):157-63. PubMed ID: 20493414
[TBL] [Abstract][Full Text] [Related]
4. Suppression of NLRP3 inflammasome by γ-tocotrienol ameliorates type 2 diabetes.
Kim Y; Wang W; Okla M; Kang I; Moreau R; Chung S
J Lipid Res; 2016 Jan; 57(1):66-76. PubMed ID: 26628639
[TBL] [Abstract][Full Text] [Related]
5. Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients.
Ruscitti P; Cipriani P; Di Benedetto P; Liakouli V; Berardicurti O; Carubbi F; Ciccia F; Alvaro S; Triolo G; Giacomelli R
Clin Exp Immunol; 2015 Oct; 182(1):35-44. PubMed ID: 26095630
[TBL] [Abstract][Full Text] [Related]
6. Inflammasome-mediated autoinflammatory disorders.
Wilson SP; Cassel SL
Postgrad Med; 2010 Sep; 122(5):125-33. PubMed ID: 20861596
[TBL] [Abstract][Full Text] [Related]
7. The inflammasome, autoinflammatory diseases, and gout.
Pétrilli V; Martinon F
Joint Bone Spine; 2007 Dec; 74(6):571-6. PubMed ID: 17714972
[TBL] [Abstract][Full Text] [Related]
8. Anakinra for cryopyrin-associated periodic syndrome.
Koné-Paut I; Galeotti C
Expert Rev Clin Immunol; 2014 Jan; 10(1):7-18. PubMed ID: 24308832
[TBL] [Abstract][Full Text] [Related]
9. The NLRP3 inflammasome: a sensor for metabolic danger?
Schroder K; Zhou R; Tschopp J
Science; 2010 Jan; 327(5963):296-300. PubMed ID: 20075245
[TBL] [Abstract][Full Text] [Related]
10. NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout.
Amaral FA; Costa VV; Tavares LD; Sachs D; Coelho FM; Fagundes CT; Soriani FM; Silveira TN; Cunha LD; Zamboni DS; Quesniaux V; Peres RS; Cunha TM; Cunha FQ; Ryffel B; Souza DG; Teixeira MM
Arthritis Rheum; 2012 Feb; 64(2):474-84. PubMed ID: 21952942
[TBL] [Abstract][Full Text] [Related]
11. [Inflammasome and interleukin 1].
Jéru I; Amselem S
Rev Med Interne; 2011 Apr; 32(4):218-24. PubMed ID: 20541850
[TBL] [Abstract][Full Text] [Related]
12. Confounding role of tumor necrosis factor in cryopyrin-associated periodic syndromes.
Banoth B; Sutterwala FS
J Clin Invest; 2017 Dec; 127(12):4235-4237. PubMed ID: 29130931
[TBL] [Abstract][Full Text] [Related]
13. KN3014, a piperidine-containing small compound, inhibits auto-secretion of IL-1β from PBMCs in a patient with Muckle-Wells syndrome.
Kaneko N; Kurata M; Yamamoto T; Shigemura T; Agematsu K; Yamazaki T; Takeda H; Sawasaki T; Koga T; Kawakami A; Yachie A; Migita K; Yoshiura KI; Urano T; Masumoto J
Sci Rep; 2020 Aug; 10(1):13562. PubMed ID: 32782316
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin-interacting protein links oxidative stress to inflammasome activation.
Zhou R; Tardivel A; Thorens B; Choi I; Tschopp J
Nat Immunol; 2010 Feb; 11(2):136-40. PubMed ID: 20023662
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.
Sokolowska M; Chen LY; Liu Y; Martinez-Anton A; Qi HY; Logun C; Alsaaty S; Park YH; Kastner DL; Chae JJ; Shelhamer JH
J Immunol; 2015 Jun; 194(11):5472-5487. PubMed ID: 25917098
[TBL] [Abstract][Full Text] [Related]
16.
Nakanishi H; Kawashima Y; Kurima K; Chae JJ; Ross AM; Pinto-Patarroyo G; Patel SK; Muskett JA; Ratay JS; Chattaraj P; Park YH; Grevich S; Brewer CC; Hoa M; Kim HJ; Butman JA; Broderick L; Hoffman HM; Aksentijevich I; Kastner DL; Goldbach-Mansky R; Griffith AJ
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):E7766-E7775. PubMed ID: 28847925
[TBL] [Abstract][Full Text] [Related]
17. Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity.
Brydges SD; Mueller JL; McGeough MD; Pena CA; Misaghi A; Gandhi C; Putnam CD; Boyle DL; Firestein GS; Horner AA; Soroosh P; Watford WT; O'Shea JJ; Kastner DL; Hoffman HM
Immunity; 2009 Jun; 30(6):875-87. PubMed ID: 19501000
[TBL] [Abstract][Full Text] [Related]
18. Shiga Toxins Activate the NLRP3 Inflammasome Pathway To Promote Both Production of the Proinflammatory Cytokine Interleukin-1β and Apoptotic Cell Death.
Lee MS; Kwon H; Lee EY; Kim DJ; Park JH; Tesh VL; Oh TK; Kim MH
Infect Immun; 2016 Jan; 84(1):172-86. PubMed ID: 26502906
[TBL] [Abstract][Full Text] [Related]
19. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation.
Sheedy FJ; Grebe A; Rayner KJ; Kalantari P; Ramkhelawon B; Carpenter SB; Becker CE; Ediriweera HN; Mullick AE; Golenbock DT; Stuart LM; Latz E; Fitzgerald KA; Moore KJ
Nat Immunol; 2013 Aug; 14(8):812-20. PubMed ID: 23812099
[TBL] [Abstract][Full Text] [Related]
20. Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome.
Duncan JA; Gao X; Huang MT; O'Connor BP; Thomas CE; Willingham SB; Bergstralh DT; Jarvis GA; Sparling PF; Ting JP
J Immunol; 2009 May; 182(10):6460-9. PubMed ID: 19414800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
